AI Summary
✦ ClarthaGujarat Fluorochemicals is a specialty chemicals manufacturer producing refrigerant gases, fluorochemicals, fluoropolymers, and battery chemicals. Its INOFLON, FLUONOX, INOFLAR, INOLUB, and Refron products serve agrochemical, pharmaceutical, and battery-material customers. Renewable-energy activities provide an additional business line, while revenue grew 5.5% year-on-year. Recent cash-flow-based value screens may support investor interest, but no disclosed catalyst indicates near-term margin expansion. Profit growth of 5.9% trails the company’s 85.6 P/E, while declining margins and 7.5% ROE indicate limited earnings quality. Debt/equity of 28.94 implies extreme leverage, which materially amplifies ROE risk and constrains financial flexibility. The stock appears rich against growth, despite recent screens identifying it among Indian cash-flow value ideas. Neutral sentiment reflects the unresolved question of whether fluoropolymer and battery-chemical demand can offset margin pressure.
Price Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 17 analysts
Fundamentals
Fundamentals institutional score is 36 using EVA spread proxy -4.5%; growth durability 54.7.
Valuation
Valuation institutional score is 36 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 16 using mean target upside -7.7%; dispersion penalty 17.7; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 81 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is skewing constructive on impact and recency. Based on 1 recent ticker-linked news items.
Signal Summary
Market intelligence remains Mixed. technical structure and market sentiment provide support, while fundamentals and valuation remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 24.1% above historical median. Valuation is stable — currently in the strongly overvalued zone (z-score: +2.02). Confidence: 88%.
Live forward EPS implies next-12-month EPS of ₹103.76. Applying the stock's normalized valuation corridor produces a fair range of ₹6,433.12 to ₹7,497.70, with base value near ₹7,035.97 (+59.3% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹103.76
Forward P/E
42.6x
Base Fair Value
₹7,035.97
Fair Range
₹6,433.12 - ₹7,497.70
Upside To Base
+59.3%
Estimate Source
Live forward EPS
Growth Estimate
-43.0%
5Y Average
63.29
Current
84.18
Overvalued
72.26
Undervalued
62.00
5Y Average
32.75
Current
43.57
Overvalued
36.33
Undervalued
29.52
5Y Average
5.31
Current
6.34
Overvalued
6.11
Undervalued
4.52
Peers & Comparison
Sector: Materials · Theme: Specialty Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
AARTI INDUSTRIES LTD AARTIINDSpecialty Chemicals | +42.5% | 5.9% | 34.6x Undervalued | -26% vs avg | +35.0% |
HINDALCO INDUSTRIES LTD HINDALCOMetals - Aluminium | +32.1% | 5.5% | 14.4x Undervalued | -69% vs avg | +58.0% |
BHARAT FORGE LTD BHARATFORGIron & Steel | +17.5% | 6.4% | 97.8x Premium | +109% vs avg | +81.6% |
GRASIM INDUSTRIES LTD GRASIMCement | +10.5% | 2.8% | 44.5x Fair | -5% vs avg | +23.4% |
DR. REDDY S LABORATORIES DRREDDYPharmaceuticals | -5.6% | 10.0% | 30.7x Undervalued | -35% vs avg | -5.0% |
APOLLO HOSPITALS ENTER. L APOLLOHOSPHospitals & Diagnostic Centres | +18.1% | 7.7% | 65.0x Premium | +39% vs avg | +23.2% |
EICHER MOTORS LTD EICHERMOTTrucks & Buses | +31.5% | 23.2% | 38.0x Undervalued | -19% vs avg | +41.7% |
BSE LIMITED BSEStock Exchanges & Ratings | +64.0% | 48.9% | 50.3x Fair | +7% vs avg | +50.1% |
GUJARAT FLUOROCHEM LTD trades at a premium (84.2x vs peer avg 46.9x), implying higher growth or quality expectations from the Specialty Chemicals cohort. Peers include AARTI INDUSTRIES LTD, HINDALCO INDUSTRIES LTD, BHARAT FORGE LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹1.21K CrMar 2026Latest net profit
₹171 CrMar 2026Latest EPS
₹15.57Mar 2026Net margin
28.0%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,470 | 1,145 | 926 | 908 | 1,043 | 1,085 | 1,199 | 1,123 | 1,158 | 1,174 | 1,131 | 1,026 | 1,211 |
| Expenses + | 915 | 803 | 753 | 745 | 841 | 841 | 901 | 816 | 871 | 841 | 771 | 740 | 876 |
| Operating Profit | 555 | 342 | 173 | 163 | 202 | 244 | 298 | 307 | 287 | 333 | 360 | 286 | 335 |
| OPM % | 38% | 30% | 19% | 18% | 19% | 22% | 25% | 27% | 25% | 28% | 32% | 28% | 28% |
| Other Income + | 19 | 27 | 7 | 13 | 19 | 11 | 13 | 14 | 16 | 17 | 7 | -10 | 3 |
| Interest | 34 | 28 | 33 | 36 | 32 | 35 | 41 | 40 | 42 | 29 | 30 | 30 | 28 |
| Depreciation | 59 | 60 | 62 | 65 | 72 | 71 | 74 | 76 | 71 | 74 | 74 | 74 | 73 |
| Profit before tax | 481 | 281 | 85 | 75 | 117 | 149 | 196 | 205 | 190 | 247 | 263 | 172 | 237 |
| Tax % | 26% | 23% | 27% | 25% | 26% | 26% | 27% | 25% | 12% | 25% | 26% | 26% | 28% |
| Net Profit + | 357 | 215 | 62 | 56 | 86 | 111 | 144 | 153 | 167 | 185 | 195 | 127 | 171 |
| EPS in Rs | 32.47 | 19.57 | 5.64 | 5.10 | 7.83 | 10.10 | 13.11 | 13.93 | 15.20 | 16.84 | 17.75 | 11.56 | 15.57 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Board Meeting Intimation for Intimation Of The Meeting Of The Board To Consider Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation